Literature DB >> 870430

In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen.

R A Cox, E Brummer, G Lecara.   

Abstract

The biological activity of C-ASWS, an alkali-soluble, water-soluble cell wall antigen isolated from mycelial-phase cells of Coccidioides immitis, was compared with that of a commercial coccidioidin (CDN; Cutter Laboratories); CDN-TS, a toluene-induced lysate of mycelial-phase cells; and spherulin, a spherule-derived extract of C. immitis. Lymphocytes obtained from healthy CDN skin test-positive donors (group I), healthy skin test-negative donors (group II), and patients with active coccidioidomycosis (group III) were assayed for lymphocyte transformation and production of macrophage inhibitory factor in response to the Coccidioides antigens. C-ASWS, CDN CDN-TS, and spherulin were each effective in eliciting blastogenic responses in lymphocytes of group I subjects. However, only C-ASWS and CDN-TS were effective in eliciting macrophage inhibitory factor production. The responses of group III subjects (patients) were depressed and, in most instances, were indistinguishable from those obtained in lymphocytes of group II subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870430      PMCID: PMC421434          DOI: 10.1128/iai.15.3.751-755.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

3.  Studies of antigens from young mycelia of Coccidioides immitis.

Authors:  D PAPPAGIANIS; C E SMITH; G S KOBAYASHI; M T SAITO
Journal:  J Infect Dis       Date:  1961 Jan-Feb       Impact factor: 5.226

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Soluble antigens of mycelia and spherules in the in vitro detection of immunity to Coccidioides immitis.

Authors:  S C Deresinski; H B Levine; D A Stevens
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

6.  Immunotherapy in recurrent coccidioidomycosis.

Authors:  D A Stevens; D Pappagianis; V A Marinkovich; T F Waddell
Journal:  Cell Immunol       Date:  1974-04       Impact factor: 4.868

7.  Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity.

Authors:  J T Harrington; P Stastny
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

8.  Macrophage migration.

Authors:  J R David
Journal:  Fed Proc       Date:  1968 Jan-Feb

9.  Immunotherapy of coccidioidomycosis.

Authors:  A Catanzaro; L Spitler; K M Moser
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  26 in total

1.  Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Measurement of cellular immunity in human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

3.  Production of a murine monoclonal antibody that recognizes an epitope specific to Coccidioides immitis antigen 2.

Authors:  R A Cox; M J Dolan; D M Magee; J N Galgiani
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.

Authors:  Y Zhu; C Yang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 6.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Coccidioides immitis fractions which are antigenic for immune T lymphocytes.

Authors:  T N Kirkland; S W Zhu; D Kruse; L L Hsu; K R Seshan; G T Cole
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.

Authors:  Neil M Ampel; Larissa A Kramer; Lijin Li; Deborah S Carroll; Kathleen M Kerekes; Suzanne M Johnson; Demosthenes Pappagianis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis.

Authors:  R A Cox; R M Pope
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

10.  Specificity of immunoglobulin E in coccidioidomycosis and correlation with disease involvement.

Authors:  R A Cox; B S Baker; D A Stevens
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.